Class II · Moderate riskTerminated Initiated Mar 15, 2021 (5 years ago)
Medroxyprogesterone acetate injectable suspension, USP 150 mg per mL 1 mL Prefilled…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
What was recalled
Medroxyprogesterone acetate injectable suspension, USP 150 mg per mL 1 mL Prefilled Syringe Rx only NDC 59762-4538-2 Distributed by: Greenstone, LLC. Peapack, NJ 07977
Recalling firm
Cardinal Health Inc.
NDC code
59762-4538-2
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0562-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified…
Mckesson Medical-Surgical Inc. Corporate OfficeNDC 55150-0330-01D-0400-2025